Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
NCT ID: NCT04757129
Last Updated: 2024-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2020-01-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombolysis Endovascular Treatment of Pulmonary Embolism
NCT03966079
Pulmonary Embolism: Mechanism and Therapeutic Innovation
NCT05360992
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
NCT05481242
Short-term Clinical Deterioration After Acute Pulmonary Embolism
NCT03915925
Effects of Information and Breathing Technique - for Patients With Respiratory Pain in Acute Pulmonary Embolism.
NCT03375723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators dynamically monitor cardiopulmonary function of participants after thrombolysis, including blood pressure, heart rate, respiratory rate, blood gas analysis, 2-dimensional echocardiography (left and right ventricular diameter, pulmonary artery pressure, interventricular septum) and laboratory tests (cTnT,pro-BNP).participants are divided into two groups: thrombolytic success group and thrombolytic failure group according the previously reported criterion which is evaluated 48h after thrombolysis.
Cardiopulmonary characteristics are analyzed to seek accurate and rapid index to reflect success of thrombolysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
thrombolysis success group
Echocardiography was performed 48 hours after thrombolysis to evaluate the success of thrombolysis according to previous report.
No interventions assigned to this group
thrombolysis failure group
Echocardiography was performed 48 hours after thrombolysis to evaluate the success of thrombolysis according to previous report.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* death within 48 hours after thrombolytic therapy
* unable to partner treatment and leaving hospitals
* missing other necessary data
* pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bin He
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bin He
Attending physician of Affiliated Hospital of Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JSSRMYY-HB-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.